BSE filing, NSE: TTL. Summary written from the filing by ALFA Finder's alert engine.
T T Ltd: key numbers
- Share price
- ₹6.24
- Market cap
- ₹161.2 Cr
- Revenue (annual)
- ₹191.5 Cr
- Net profit (annual)
- ₹0.29 Cr
- P/E (TTM)
- 310.0×Sector 49.0×
- Promoter holding
- 52.42%+1.31% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from T T Ltd
All →T T Management Change
T T Ltd informed the exchange that Independent Director Rahul Jain retired upon completing his tenure on 19 October 2026. He ceased to be a Board member effective 20 October 2026.
T T Other Announcement
T T Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure.
T T Promoter Buying: ₹0.5 Cr
T T Brands Limited, a promoter group entity, acquired 620,740 equity shares of T T Limited via open market purchase. The transaction valued at ₹0.50 Crore increases promoter stake.
- Value
- ₹0.50 Cr
- Promoter stake change
- +0.24%
T T Promoter Buying: ₹0.52 Cr
T T Brands Limited (Promoter Group) purchased 697,248 equity shares of T T Limited from the open market for ₹0.52 Crore.
- Value
- ₹0.52 Cr
- Promoter stake change
- +0.27%
T T Promoter Buying: ₹0.03 Cr
T T Brands Limited, a promoter group entity, acquired 36,050 equity shares of T T Limited. The transaction was conducted through an open market purchase on September 28, 2026.
- Value
- ₹0.03 Cr
- Promoter stake change
- +0.01%
T T Other Announcement
T.T. Limited announced a special window for transfer and dematerialization of physical securities from February 05, 2026, to February 04, 2027. This follows SEBI guidelines for shares traded before 2019.
- Execution
- February 05, 2026 to February 04, 2027
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.